Biotech executives, having pledged fair pricing, criticize drugmaker for steep hike

A group of eight leading biotech executives are criticizing a little-known Florida drugmaker for dramatically increasing the price of an injectable drug, penning a public letter that questions the company's attempts to justify its actions.